Whole tumor tissue sections were immunostained for CD56 and polySia (serial sections) and expression levels of CD56 and polySia were analyzed relative to multiple variables: tumor staging, receptor expression, disease progression/recurrence and disease-specific overall survival. Here, NCAM1 is linked to neoplasm.